Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 6105244)

2.

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.

Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, Schinagl D, Oei B, Rodenhuis C, Horiot JC, Struikmans H, Van Limbergen E, Kirova Y, Elkhuizen P, Bongartz R, Miralbell R, Morgan D, Dubois JB, Remouchamps V, Mirimanoff RO, Collette S, Collette L; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups.

Lancet Oncol. 2015 Jan;16(1):47-56. doi: 10.1016/S1470-2045(14)71156-8. Epub 2014 Dec 9. Erratum in: Lancet Oncol. 2015 Jan;16(1):e6.

PMID:
25500422
3.

Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.

McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK, Sahin A, Strom EA, Buzdar A, Valero V, Hortobagyi GN, Hunt KK, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):392-8. doi: 10.1016/j.ijrobp.2014.02.013. Epub 2014 Apr 7.

PMID:
24721590
4.

Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.

Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, Luini A, Veronesi P, Galimberti V, Zurrida S, Leonardi MC, Lazzari R, Cattani F, Gentilini O, Intra M, Caldarella P, Ballardini B.

Lancet Oncol. 2013 Dec;14(13):1269-77. doi: 10.1016/S1470-2045(13)70497-2. Epub 2013 Nov 11.

PMID:
24225155
5.

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, Flyger HL, Massarut S, Alvarado M, Saunders C, Eiermann W, Metaxas M, Sperk E, Sütterlin M, Brown D, Esserman L, Roncadin M, Thompson A, Dewar JA, Holtveg HM, Pigorsch S, Falzon M, Harris E, Matthews A, Brew-Graves C, Potyka I, Corica T, Williams NR, Baum M; TARGIT trialists' group.

Lancet. 2014 Feb 15;383(9917):603-13. doi: 10.1016/S0140-6736(13)61950-9. Epub 2013 Nov 11. Erratum in: Lancet. 2014 Feb 15;383(9917):602.

6.

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR; START Trialists' Group.

Lancet Oncol. 2013 Oct;14(11):1086-94. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.

PMID:
24055415
7.

Locoregional recurrence of pT3N0M0 breast cancer after mastectomy is not higher than that of pT1-2N0M0: an analysis for radiotherapy.

Sun JY, Wu SG, Li S, Li FY, Chen WF, Lin Q, He ZY.

Cancer Sci. 2013 May;104(5):599-603. doi: 10.1111/cas.12130. Epub 2013 Mar 29.

PMID:
23421381
8.

One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgery.

Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Rödel C, Souchon R, Wenz F, Sauer R.

Strahlenther Onkol. 2012 Jun;188(6):461-3. doi: 10.1007/s00066-012-0092-5. No abstract available.

PMID:
22441440
9.

Breast cancer local therapy: what is its effect on mortality?

Benson JR, Teo KA.

World J Surg. 2012 Jul;36(7):1460-74. doi: 10.1007/s00268-012-1468-5. Review.

PMID:
22392352
10.

Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.

Litière S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, Van Limbergen E, Baaijens MH, Bogaerts J, Bartelink H.

Lancet Oncol. 2012 Apr;13(4):412-9. doi: 10.1016/S1470-2045(12)70042-6. Epub 2012 Feb 27.

PMID:
22373563
11.

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.

Abdulkarim BS, Cuartero J, Hanson J, Deschênes J, Lesniak D, Sabri S.

J Clin Oncol. 2011 Jul 20;29(21):2852-8. doi: 10.1200/JCO.2010.33.4714. Epub 2011 Jun 13.

12.

Impact of immediate breast reconstruction on breast cancer recurrence and survival.

Nedumpara T, Jonker L, Williams MR.

Breast. 2011 Oct;20(5):437-43. doi: 10.1016/j.breast.2011.04.006. Epub 2011 May 20.

PMID:
21601458
13.

Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and doxorubicin-based chemotherapy for breast cancer.

Reddy JP, Levy L, Oh JL, Strom EA, Perkins GH, Buchholz TA, Woodward WA.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1453-7. doi: 10.1016/j.ijrobp.2010.04.015. Epub 2010 Dec 16.

PMID:
21168284
14.

Outcomes of node-negative breast cancer 5 centimeters and larger treated with and without postmastectomy radiotherapy.

Goulart J, Truong P, Woods R, Speers CH, Kennecke H, Nichol A.

Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):758-64. doi: 10.1016/j.ijrobp.2010.02.014. Epub 2010 Jun 18.

PMID:
20646860
15.
16.

High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.

Kyndi M, Overgaard M, Nielsen HM, Sørensen FB, Knudsen H, Overgaard J.

Radiother Oncol. 2009 Jan;90(1):74-9. doi: 10.1016/j.radonc.2008.04.014. Epub 2008 May 28.

PMID:
18471914
18.

Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.

Mladenovic J, Susnjar S, Gavrilovic D, Borojevic N.

J BUON. 2007 Apr-Jun;12(2):215-20.

PMID:
17600875
19.

Once more confirmed: adjuvant radiotherapy and improved local control provide a significant survival benefit for early breast cancer patients.

Sautter-Bihl ML, Sauer R.

Strahlenther Onkol. 2006 Apr;182(4):199-201. No abstract available.

PMID:
16622620
20.

[Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].

Fodor J, Mózsa E, Zaka Z, Polgár C, Major T.

Magy Onkol. 2005;49(3):203, 205-8. Epub 2005 Oct 25. Hungarian.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk